SonoVol Awarded Phase II National Institutes of Health SBIR Grant

In a continuation of the Phase I pilot study to merge ultrasound and bioluminescence, SonoVol will add photoacoustics to its cancer imaging research platform. This two year $1.8M Phase II R&D project, entitled “Development of a mobile and automated platform for multiplexed multi-modality imaging” will begin within the next month.

The system will be validated in collaboration with researchers at Johns Hopkins and UNC Chapel Hill. The device will include clinically translatable imaging approaches for tumor assessment, forming a direct link between preclinical findings and actionable clinical cancer assessment protocols.